CLGN — Collplant Biotechnologies Share News
0.000.00%
Last trade - 00:00- $8.31m
- $5.75m
- $2.37m
Brief: Cellink And CollPlant Enter Collaboration Agreement
Brief: CELLINK, CollPlant Enter Collaboration Agreement
Brief: Collplant Biotechnologies Q3 Non-GAAP Loss Per Share $0.26
Brief: Collplant Appoints Medical Aesthetics Veteran Alisa Lask To Board Of Directors
Brief: Collplant Reports Q2 Non-GAAP Loss Per Share Of $0.25
3D Systems surges on bioprinted deal with CollPlant Biotechnologies
Brief: Collplant Announces Effectiveness Of Uplisting To The Nasdaq Global Market Ordinary Shares Replace ADSS
Brief: CollPlant Biotechnologies Reports First Quarter 2021 Financial Results With Record Revenues Of $14.5 Million
Brief: CollPlant Announces Uplisting To Nasdaq Global Market And Transition To Trading Of Ordinary Shares Instead Of ADSs
Brief: CollPlant Appoints Additive Manufacturing Executive, Hugh Evans To Its Board Of Directors
Brief: CollPlant Biotechnologies Reports Year End Financial Results For Fiscal Year 2020
Brief: Collplant Announces Development And Global Commercialization Agreement With Allergan Aesthetics
Brief: Collplant Biotechnologies To Supply Rhcollagen To Stemcell Technologies For Use In A Broad Range Of Cell Culture Applications
Brief: Collplant Biotechnologies Posts Q3 Earnings Per Share $0.10
Brief: Collplant Announces Development Program Of Antiviral Agent For Potential Treatment Of Covid-19 Patients
Brief: Collplant And United Therapeutics Announce Collaboration To Include 3D Bioprinting Of Human Kidneys For Transplant
Brief: Collplant Biotechnologies Signs Distribution Agreement For Its Vergenix Flowable Gel Product
Brief: Collplant Biotechnologies Reports Q2 Loss Per Share Of $0.28
Brief: Collplant Biotech Files For Shelf Of Up To 3.3 Mln Shares By Selling Shareholders